CA
EBS icon

CoreCap Advisors’s Emergent Biosolutions EBS Stock Holding History

CoreCap Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9
Closed -$75 – 3210
2026
Q1 		$75 Sell
9
-250
-97% -$2.59K ﹤0.01% 2861
2025
Q4 		$3.2K Hold
259
– – ﹤0.01% 2348
2025
Q3 		$2.28K Sell
259
-2,600
-91% -$20.2K ﹤0.01% 2356
2025
Q2 		$18.2K Sell
2,859
-1,825
-39% -$10.4K ﹤0.01% 1650
2025
Q1 		$22.8K Sell
4,684
-3,550
-43% -$29.4K ﹤0.01% 1477
2024
Q4 		$78.7K Sell
8,234
-2,500
-23% -$22.9K ﹤0.01% 1013
2024
Q3 		$89.6K Sell
10,734
-13,750
-56% -$125K ﹤0.01% 962
2024
Q2 		$167K Sell
24,484
-6,700
-21% -$28.8K 0.02% 395
2024
Q1 		$78.9K Buy
31,184
+17,450
+127% +$39.3K ﹤0.01% 937
2023
Q4 		$33K Buy
+13,734
New +$32.3K ﹤0.01% 596
2022
Q4 		$106 Buy
+9
New +$139 ﹤0.01% 2308
2022
Q3 		– Sell
-9
Closed – – 944
2022
Q2 		$0 Buy
+9
New +$307 ﹤0.01% 2165
2022
Q1 		– Sell
-9
Closed -$1K – 952
2021
Q4 		$1K Buy
+9
New +$407 ﹤0.01% 2103

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

CoreCap Advisors's EBS Position: Q2 2026 in Review

CoreCap Advisors sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 9 shares — an estimated $75 sold.

CoreCap Advisors first reported a position in EBS in Q4 2021 and held it in 13 quarters. The position peaked at $167K in Q2 2024. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • CoreCap Advisors reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • CoreCap Advisors sold 9 Emergent Biosolutions shares in Q2 2026, an estimated $75.
  • CoreCap Advisors first reported a position in Emergent Biosolutions in Q4 2021 and held it in 13 quarters.
  • CoreCap Advisors's Emergent Biosolutions position peaked at $167K in Q2 2024.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.